Compartmentalized drug localization studies in extracellular vesicles for anticancer therapy
Open Access
- 8 November 2023
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Nanoscale Advances
- Vol. 5 (24) , 6830-6836
Abstract
In the development of therapeutic extracellular vesicles (EVs), drug encapsulation efficiencies are significantly lower when compared with synthetic nanomedicines. This is due to the hierarchical structure of the EV membrane and the physicochemical properties of the candidate drug (molecular weight, hydrophilicity, lipophilicity, and so on). As a proof of concept, here we demonstrated the importance of drug compartmentalization in EVs as an additional parameter affecting the therapeutic potential of drug-loaded EVs. In human adipose mesenchymal stem cell (hADSC) derived EVs, we performed a comparative drug loading analysis using two formulations of the same chemotherapeutic molecule – free doxorubicin (DOX) and 1,2-distearoyl-sn-glycero-3-phosphoethanolamine (DSPE) lipid-conjugated doxorubicin (L-DOX) – to enhance the intracellular uptake and therapeutic efficacy. By nano surface energy transfer (NSET) and molecular simulation techniques, along with cryo-TEM analysis, we confirmed the differential compartmentalization of these two molecules in hADSC EVs. L-DOX was preferentially adsorbed onto the surface of the EV, due to its higher lipophilicity, whereas free DOX was mostly encapsulated within the EV core. Also, the L-DOX loaded EV (LDOX@EV) returned an almost three-fold higher DOX content as compared to the free DOX loaded EV (DOX@EV), for a given input mass of drug. Based on the cellular investigations, L-DOX@EV showed higher cell internalization than DOX@EV. Also, in comparison with free L-DOX, the magnitude of therapeutic potential enhancement displayed by the surface compartmentalized L-DOX@EV is highly promising and can be exploited to overcome the sensitivity of many potential drugs, which are impermeable in nature. Overall, this study illustrates the significance of drug compartmentalization in EVs and how this could affect intracellular delivery, loading efficiency, and therapeutic effect. This will further lay the foundation for the future systematic investigation of EV-based biotherapeutic delivery platforms for personalized medicine.Keywords
Funding Information
- Horizon 2020 (754490)
- Istituto Italiano di Tecnologia
- Department of Biotechnology, Ministry of Science and Technology, India
This publication has 40 references indexed in Scilit:
- Interaction between PEG lipid and DSPE/DSPC phospholipids: An insight of PEGylation degree and kinetics of de-PEGylationColloids and Surfaces B: Biointerfaces, 2017
- Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasivenessScientific Reports, 2017
- Ultrastructural Characterization of the Lower Motor System in a Mouse Model of Krabbe DiseaseScientific Reports, 2016
- Detailed Analysis of Protein Topology of Extracellular Vesicles–Evidence of Unconventional Membrane Protein OrientationScientific Reports, 2016
- Trehalose prevents aggregation of exosomes and cryodamageScientific Reports, 2016
- Design and characterization of gadolinium infused theranostic liposomesRSC Advances, 2016
- Presence of Cx43 in extracellular vesicles reduces the cardiotoxicity of the anti‐tumour therapeutic approach with doxorubicinJournal of Extracellular Vesicles, 2016
- Bioinspired Exosome-Mimetic Nanovesicles for Targeted Delivery of Chemotherapeutics to Malignant TumorsACS Nano, 2013
- A Surface Energy Transfer Nanoruler for Measuring Binding Site Distances on Live Cell SurfacesJournal of the American Chemical Society, 2010
- Free Energy and Entropy of Activation for Phospholipid Flip-Flop in Planar Supported Lipid BilayersThe Journal of Physical Chemistry B, 2010